These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chemotherapy administration directly into the fourth ventricle in a nonhuman primate model. Sandberg DI; Peet MM; Johnson MD; Cole P; Koru-Sengul T; Luqman AW J Neurosurg Pediatr; 2012 May; 9(5):530-41. PubMed ID: 22546032 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. Shapiro WR; Young DF; Mehta BM N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016 [TBL] [Abstract][Full Text] [Related]
6. Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates. Kimelberg HK; Biddlecome SM; Bourke RS Cancer Res; 1977 Jan; 37(1):157-65. PubMed ID: 401470 [TBL] [Abstract][Full Text] [Related]
7. Active transport of methotrexate from cerebrospinal fluid in humans. Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced? Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463 [TBL] [Abstract][Full Text] [Related]
9. A primate model for study of methotrexate pharmacokinetics in the central nervous system. Poplack DG; Bleyer WA; Wood JH; Kostolich M; Savitch JL; Ommaya AK Cancer Res; 1977 Jul; 37(7 Pt 1):1982-5. PubMed ID: 405092 [TBL] [Abstract][Full Text] [Related]
10. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Blasberg RG; Patlak CS; Shapiro WR Cancer Treat Rep; 1977 Jul; 61(4):633-41. PubMed ID: 406996 [No Abstract] [Full Text] [Related]
11. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients]. Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792 [TBL] [Abstract][Full Text] [Related]
12. Prediction of methotrexate CNS distribution in different species - influence of disease conditions. Westerhout J; van den Berg DJ; Hartman R; Danhof M; de Lange EC Eur J Pharm Sci; 2014 Jun; 57():11-24. PubMed ID: 24462766 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intrathecal gemcitabine in nonhuman primates. Egorin MJ; Zuhowski EG; McCully CM; Blaney SM; Kerr JZ; Berg SL; Balis FM Clin Cancer Res; 2002 Jul; 8(7):2437-42. PubMed ID: 12114450 [TBL] [Abstract][Full Text] [Related]
15. [Cis-diamminedichloroplatinum penetration into the cerebrospinal fluid of the lateral ventricle, postoperative cavity, and lumbar subarachnoid space with or without pre-intravenous mannitol administration in patients with brain metastasis from lung cancer]. Nakagawa H; Yamada M; Tamura M; Yoshida M; Shindo M; Nishiyama H; Sakai S Gan To Kagaku Ryoho; 2014 Mar; 41(3):317-24. PubMed ID: 24743276 [TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia. Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460 [TBL] [Abstract][Full Text] [Related]
17. Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits. Scism JL; Powers KM; Artru AA; Chambers AC; Lewis L; Adkison KK; Kalhorn TF; Shen DD Drug Metab Dispos; 1997 Dec; 25(12):1337-46. PubMed ID: 9394022 [TBL] [Abstract][Full Text] [Related]
18. Direct administration of methotrexate into the central nervous system of primates. Part 1: Distribution and degradation of methotrexate in nervous and systemic tissue after intraventricular injection. Kimelberg HK; Kung D; Watson RE; Reiss FL; Biddlecome SM; Bourke RS J Neurosurg; 1978 Jun; 48(6):883-94. PubMed ID: 96228 [TBL] [Abstract][Full Text] [Related]
19. A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma. Zamboni WC; Gajjar AJ; Mandrell TD; Einhaus SL; Danks MK; Rogers WP; Heideman RL; Houghton PJ; Stewart CF Clin Cancer Res; 1998 Oct; 4(10):2537-44. PubMed ID: 9796988 [TBL] [Abstract][Full Text] [Related]
20. Dose-related increases in cerebrospinal fluid concentrations of methotrexate in a postoperative patient with glioblastoma. Morikawa N; Mori T; Kamenofuchi Y; Kawashima H; Takeyama M; Hori S Ann Pharmacother; 1999 Sep; 33(9):952-6. PubMed ID: 10492499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]